Cumberland Pharmaceuticals, Inc. (CPIX)
8.49
+0.01
(+0.12%)
USD |
NASDAQ |
Oct 23, 16:00
7.48
-1.01
(-11.90%)
After-Hours: 20:00
Cumberland Pharmaceuticals Market Cap : 127.21M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 127.21M |
| October 22, 2026 | 127.06M |
| October 21, 2026 | 122.41M |
| October 20, 2026 | 119.27M |
| October 19, 2026 | 100.39M |
| October 16, 2026 | 107.58M |
| October 15, 2026 | 112.97M |
| October 14, 2026 | 112.22M |
| October 13, 2026 | 107.43M |
| October 12, 2026 | 104.88M |
| October 09, 2026 | 105.33M |
| October 08, 2026 | 104.58M |
| October 07, 2026 | 103.23M |
| October 06, 2026 | 106.98M |
| October 05, 2026 | 106.23M |
| October 02, 2026 | 110.73M |
| October 01, 2026 | 112.52M |
| September 30, 2026 | 117.32M |
| September 29, 2026 | 114.62M |
| September 28, 2026 | 115.67M |
| September 25, 2026 | 114.02M |
| September 24, 2026 | 120.01M |
| September 23, 2026 | 118.97M |
| September 22, 2026 | 122.86M |
| September 21, 2026 | 113.72M |
| Date | Value |
|---|---|
| September 18, 2026 | 109.68M |
| September 17, 2026 | 107.73M |
| September 16, 2026 | 104.58M |
| September 15, 2026 | 99.49M |
| September 14, 2026 | 100.39M |
| September 11, 2026 | 95.74M |
| September 10, 2026 | 97.09M |
| September 09, 2026 | 94.24M |
| September 08, 2026 | 99.19M |
| September 04, 2026 | 101.74M |
| September 03, 2026 | 101.14M |
| September 02, 2026 | 97.69M |
| September 01, 2026 | 98.29M |
| August 31, 2026 | 100.24M |
| August 28, 2026 | 126.76M |
| August 27, 2026 | 129.60M |
| August 26, 2026 | 134.40M |
| August 25, 2026 | 130.35M |
| August 24, 2026 | 117.47M |
| August 21, 2026 | 114.62M |
| August 20, 2026 | 112.37M |
| August 19, 2026 | 114.62M |
| August 18, 2026 | 114.32M |
| August 17, 2026 | 115.07M |
| August 14, 2026 | 116.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.668B |
| Corcept Therapeutics, Inc. | 9.266B |
| Veru, Inc. | 38.19M |
| Johnson & Johnson | 635.02B |
| Eli Lilly & Co. | 1.199T |
Market Cap Related Metrics
| PS Ratio | 4.063 |
| PEG Ratio | -0.0481 |
| Price to Book Value | 7.295 |
| Price to Free Cash Flow | 203.60 |
| Price | 8.49 |
| Earnings Yield | -8.59% |
| PEGY Ratio | -0.0481 |